Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Dec 01, 2022

BUY
$59.54 - $68.01 $1.99 Million - $2.27 Million
33,411 Added 20.25%
198,429 $12.2 Million
Q3 2022

Oct 31, 2022

BUY
$59.54 - $68.01 $1.99 Million - $2.27 Million
33,411 Added 20.25%
198,429 $12.2 Million
Q2 2022

Dec 01, 2022

BUY
$57.72 - $65.01 $1.48 Million - $1.66 Million
25,589 Added 18.35%
165,018 $10.2 Million
Q2 2022

Aug 02, 2022

BUY
$57.72 - $65.01 $1.48 Million - $1.66 Million
25,589 Added 18.35%
165,018 $10.2 Million
Q1 2022

Dec 01, 2022

BUY
$57.92 - $72.58 $1.14 Million - $1.43 Million
19,663 Added 16.42%
139,429 $8.29 Million
Q1 2022

May 06, 2022

BUY
$57.92 - $72.58 $1.14 Million - $1.43 Million
19,663 Added 16.42%
139,429 $8.29 Million
Q4 2021

Dec 01, 2022

BUY
$64.88 - $73.64 $3.33 Million - $3.78 Million
51,366 Added 75.1%
119,766 $8.7 Million
Q4 2021

Feb 09, 2022

BUY
$64.88 - $73.64 $3.33 Million - $3.78 Million
51,366 Added 75.1%
119,766 $8.7 Million
Q3 2021

Dec 01, 2022

BUY
$67.69 - $73.03 $3.62 Million - $3.9 Million
53,448 Added 357.46%
68,400 $4.78 Million
Q3 2021

Nov 05, 2021

BUY
$67.69 - $73.03 $3.62 Million - $3.9 Million
53,448 Added 357.46%
68,400 $4.78 Million
Q2 2021

Dec 01, 2022

SELL
$63.47 - $69.35 $55,853 - $61,027
-880 Reduced 5.56%
14,952 $1.03 Million
Q2 2021

Aug 06, 2021

SELL
$63.47 - $69.35 $55,853 - $61,027
-880 Reduced 5.56%
14,952 $1.03 Million
Q1 2021

Dec 01, 2022

SELL
$60.0 - $68.46 $189,960 - $216,744
-3,166 Reduced 16.66%
15,832 $1.02 Million
Q1 2021

Apr 30, 2021

SELL
$60.0 - $68.46 $189,960 - $216,744
-3,166 Reduced 16.66%
15,832 $1.02 Million
Q4 2020

Dec 01, 2022

SELL
$56.65 - $64.55 $469,855 - $535,377
-8,294 Reduced 30.39%
18,998 $1.11 Million
Q4 2020

Feb 03, 2021

SELL
$56.65 - $64.55 $469,855 - $535,377
-8,294 Reduced 30.39%
18,998 $1.11 Million
Q3 2020

Dec 01, 2022

SELL
$62.1 - $78.08 $458,732 - $576,776
-7,387 Reduced 21.3%
27,292 $1.73 Million
Q3 2020

Nov 03, 2020

SELL
$62.1 - $78.08 $458,732 - $576,776
-7,387 Reduced 21.3%
27,292 $1.73 Million
Q2 2020

Dec 01, 2022

SELL
$72.34 - $84.0 $11.8 Million - $13.8 Million
-163,750 Reduced 82.52%
34,679 $2.67 Million
Q2 2020

Aug 06, 2020

SELL
$72.34 - $84.0 $3.1 Million - $3.6 Million
-42,884 Reduced 55.29%
34,679 $2.67 Million
Q1 2020

Apr 24, 2020

BUY
$62.63 - $80.22 $1,691 - $2,165
27 Added 0.03%
77,563 $5.8 Million
Q4 2019

Feb 10, 2020

SELL
$61.62 - $67.78 $1.52 Million - $1.67 Million
-24,711 Reduced 24.17%
77,536 $5.04 Million
Q3 2019

Nov 06, 2019

SELL
$62.51 - $69.0 $1.94 Million - $2.14 Million
-31,028 Reduced 23.28%
102,247 $6.48 Million
Q2 2019

Aug 09, 2019

BUY
$61.87 - $69.38 $235,786 - $264,407
3,811 Added 2.94%
133,275 $9 Million
Q1 2019

May 13, 2019

SELL
$62.53 - $70.05 $1.59 Million - $1.78 Million
-25,476 Reduced 16.44%
129,464 $8.42 Million
Q4 2018

Feb 13, 2019

SELL
$60.54 - $79.0 $2.09 Million - $2.73 Million
-34,511 Reduced 18.22%
154,940 $9.69 Million
Q3 2018

Nov 14, 2018

SELL
$71.28 - $78.92 $371,725 - $411,567
-5,215 Reduced 2.68%
189,451 $0
Q2 2018

Aug 10, 2018

SELL
$64.88 - $75.68 $319,339 - $372,496
-4,922 Reduced 2.47%
194,666 $0
Q1 2018

May 07, 2018

BUY
$72.84 - $88.8 $1.37 Million - $1.67 Million
18,802 Added 10.4%
199,588 $15 Million
Q4 2017

Feb 08, 2018

BUY
$71.15 - $83.52 $175,242 - $205,709
2,463 Added 1.38%
180,786 $0
Q3 2017

Nov 13, 2017

BUY
$72.11 - $85.47 $3.98 Million - $4.71 Million
55,161 Added 44.79%
178,323 $0
Q2 2017

Aug 07, 2017

BUY
N/A
123,162
123,162 $0

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Mufg Americas Holdings Corp Portfolio

Follow Mufg Americas Holdings Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mufg Americas Holdings Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mufg Americas Holdings Corp with notifications on news.